Search the Health Library
Get the facts on diseases, conditions, tests and procedures.
I Want To...
Find a Doctor
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
Cytoreductive Surgery and Heated Chemotherapy (HIPEC)
Recent advances in cancer treatments provide Johns Hopkins more effective treatment options for certain late stage gastrointestinal cancers than ever before. A technique called cytoreductive (debulking) surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) has been shown to be an effective treatment option for certain peritoneal surface malignancy cancers such as selected stage IV colon cancer and other gastrointestinal cancers including appendiceal cancers and pseudomyxoma peritonei. The peritoneal cavity is a space wrapped between two membranes layering the abdominal wall and organs around the abdomen.
The technique is a two-step process:
- Surgically removing any visible tumor or cancer, and then
- Delivering heated chemotherapy drugs to the affected area.
During the second phase of treatment a heated chemotherapy solution is circulated in the abdominal cavity to treat any cancer cells that may remain. The combination of heat and chemotherapy is believed to be more effective than standard chemotherapy treatment for certain patients because it can access and kill more cancer cells than can be found with the naked eye.
Recent studies have shown that cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy is beneficial for certain patients with late-stage gastrointestinal cancers such as colorectal cancers. The procedure can potentially extend their life and also improve quality of life for patients with late stage disease. Since the chemotherapy is delivered internally, some of the traditional side effects of oral or intravenous chemotherapy drugs may be avoided.
Quality of care
HIPEC is a novel approach to treating late stage gastrointestinal cancers, but it is also considered a risky procedure. Before identifying candidates for HIPEC, Johns Hopkins physicians evaluate the patient case rigorously and discuss the risks and benefits with the patient. They will work with your doctors to determine if the heated chemotherapy wash may be an effective treatment for you.
Meet our specialist
Professor of Oncology
Professor of Urology
Director of Sarcoma and Peritoneal Surface Malignancy Program
Chief, Mixed Tumor Services
A Johns Hopkins surgeon can determine if cytoreductive surgery and heated chemotherapy is the right treatment option for you or your patient.
For a consultation, call 443-997-1508.